ARQT
Arcutis Biotherapeutics Inc
NASDAQ: ARQT · HEALTHCARE · BIOTECHNOLOGY
$22.37
-3.95% today
Updated 2026-04-29
Market cap
$2.91B
P/E ratio
—
P/S ratio
7.75x
EPS (TTM)
$-0.13
Dividend yield
—
52W range
$12 – $32
Volume
1.3M
Arcutis Biotherapeutics Inc (ARQT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-4.29%
Operating margin
14.20%
ROE
-9.30%
ROA
-1.96%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-4.98M | — | — | — |
| 2018 | $0.00 | $-19.25M | — | — | — |
| 2019 | $0.00 | $-42.00M | — | — | — |
| 2020 | $0.00 | $-135.68M | — | — | — |
| 2021 | $0.00 | $-205.90M | — | — | — |
| 2022 | $3.69M | $-311.46M | 79.54% | -8,183.04% | -8,449.76% |
| 2023 | $59.61M | $-262.14M | 91.63% | -404.49% | -439.79% |
| 2024 | $196.54M | $-140.04M | 90.27% | -65.33% | -71.25% |
| 2025 | $376.07M | $-16.14M | 90.24% | -3.25% | -4.29% |